Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

OriginalsprogEngelsk
TidsskriftThe Lancet Diabetes & Endocrinology
Vol/bind8
Udgave nummer4
Sider (fra-til)313-324
Antal sider12
ISSN2213-8587
DOI
StatusUdgivet - 2020

ID: 239075974